{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-26-000068","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2026-11-10T21:17:45+00:00","discovered_at":"2026-11-10T21:19:00.228392+00:00","generated_at":"2026-11-10T21:19:16.786721+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.62,"calibrated_materiality_score":0.62,"confidence":"high","headline":"PetMeds Q2 net sales fall 19.4% to $35.8M; net loss narrows to $6.4M ($0.31/sh)","bullets":["Net sales of $35.8M vs $44.4M a year ago, down 19.4%, driven by lower prescription medication sales and higher consumer promotional usage.","Net loss of $6.4M, or $(0.31) per diluted share, versus a net loss of $8.5M, or $(0.41) per diluted share, in the prior-year quarter.","Adjusted EBITDA was $(3.6)M, worse than $(2.3)M a year ago; lower G&A and advertising spend was offset by weaker gross profit and lower manufacturer rebates.","CEO Jeff Willard said operations are \"stabilized\"; customer acquisition cost fell 32% YoY, with focus on repositioning the brand and improving retention.","No financial guidance was provided in the release; earnings webcast scheduled for 4:30pm Eastern on November 10, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-26-000068","json":"https://secwatch.observer/filing/0001040130-26-000068.json","markdown":"https://secwatch.observer/filing/0001040130-26-000068.md","text":"https://secwatch.observer/filing/0001040130-26-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000068/0001040130-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000068/pets-20261110.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T21:19:16.786721+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}